3.25.1 html 180 263 1 true 56 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfOperations CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Statements 4 false false R5.htm 100040 - Statement - CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfOperationsParenthetical CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (Parenthetical) Statements 5 false false R6.htm 100050 - Statement - CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfComprehensiveLoss CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE LOSS Statements 6 false false R7.htm 100060 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfStockholdersEquity CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY Statements 7 false false R8.htm 100070 - Statement - CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfStockholdersEquityParenthetical CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (Parenthetical) Statements 8 false false R9.htm 100080 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/StatementCondensedConsolidatedStatementOfCashFlows CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS Statements 9 false false R10.htm 995410 - Disclosure - Pay vs Performance Disclosure Sheet http://xbrl.sec.gov/ecd/role/PvpDisclosure Pay vs Performance Disclosure Notes 10 false false R11.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 11 false false R12.htm 995457 - Disclosure - Nature of the Business Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNatureOfBusiness Nature of the Business Notes 12 false false R13.htm 995467 - Disclosure - Summary of Significant Accounting Policies Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 13 false false R14.htm 995477 - Disclosure - Marketable Securities Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureMarketableSecurities Marketable Securities Notes 14 false false R15.htm 995487 - Disclosure - Fair Value Measurements Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureFairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 995497 - Disclosure - Prepaids and Other Assets Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePrepaidsAndOtherAssets Prepaids and Other Assets Notes 16 false false R17.htm 995507 - Disclosure - Property and Equipment, net Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePropertyAndEquipmentNet Property and Equipment, net Notes 17 false false R18.htm 995517 - Disclosure - Accrued Expenses Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureAccruedExpenses Accrued Expenses Notes 18 false false R19.htm 995527 - Disclosure - Other Significant Agreements Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureOtherSignificantAgreements Other Significant Agreements Notes 19 false false R20.htm 995537 - Disclosure - Commitments and Contingencies Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 20 false false R21.htm 995557 - Disclosure - Common Stock Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureCommonStock Common Stock Notes 21 false false R22.htm 995567 - Disclosure - Equity-Based Compensation Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensation Equity-Based Compensation Notes 22 false false R23.htm 995577 - Disclosure - Related Parties Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureRelatedParties Related Parties Notes 23 false false R24.htm 995587 - Disclosure - Net Loss Per Share Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNetLossPerShare Net Loss Per Share Notes 24 false false R25.htm 995597 - Disclosure - Operating Leases Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureOperatingLeases Operating Leases Notes 25 false false R26.htm 995607 - Disclosure - Segment Information Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformation Segment Information Notes 26 false false R27.htm 995617 - Disclosure - Subsequent Events Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 27 false false R28.htm 995627 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 28 false false R29.htm 995637 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 29 false false R30.htm 995647 - Disclosure - Marketable Securities (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureMarketableSecuritiesTables Marketable Securities (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureMarketableSecurities 30 false false R31.htm 995657 - Disclosure - Fair Value Measurements (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureFairValueMeasurements 31 false false R32.htm 995667 - Disclosure - Prepaids and Other Assets (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePrepaidsAndOtherAssetsTables Prepaids and Other Assets (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePrepaidsAndOtherAssets 32 false false R33.htm 995677 - Disclosure - Property and Equipment, net (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePropertyAndEquipmentNet 33 false false R34.htm 995687 - Disclosure - Accrued Expenses (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureAccruedExpensesTables Accrued Expenses (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureAccruedExpenses 34 false false R35.htm 995697 - Disclosure - Equity-Based Compensation (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationTables Equity-Based Compensation (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensation 35 false false R36.htm 995707 - Disclosure - Net Loss Per Share (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNetLossPerShareTables Net Loss Per Share (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNetLossPerShare 36 false false R37.htm 995717 - Disclosure - Segment Information (Tables) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformationTables Segment Information (Tables) Tables http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformation 37 false false R38.htm 995727 - Disclosure - Nature of the Business (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNatureOfBusinessDetails Nature of the Business (Details) Details http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNatureOfBusiness 38 false false R39.htm 995737 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails Summary of Significant Accounting Policies - Additional Information (Details) Details 39 false false R40.htm 995747 - Disclosure - Summary of Significant Accounting Policies - Property and Equipment (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPropertyAndEquipmentDetails Summary of Significant Accounting Policies - Property and Equipment (Details) Details 40 false false R41.htm 995757 - Disclosure - Marketable Securities - Schedule of Company's investing portfolio (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureMarketableSecuritiesScheduleOfCompanySInvestingPortfolioDetails Marketable Securities - Schedule of Company's investing portfolio (Details) Details 41 false false R42.htm 995767 - Disclosure - Marketable Securities - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureMarketableSecuritiesAdditionalInformationDetails Marketable Securities - Additional Information (Details) Details 42 false false R43.htm 995777 - Disclosure - Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Reoccurring Basis (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureFairValueMeasurementsScheduleOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnAReoccurringBasisDetails Fair Value Measurements - Schedule of Financial Assets and Liabilities Measured at Fair Value on a Reoccurring Basis (Details) Details 43 false false R44.htm 995787 - Disclosure - Prepaids and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePrepaidsAndOtherAssetsScheduleOfPrepaidExpensesAndOtherAssetsDetails Prepaids and Other Assets - Schedule of Prepaid Expenses and Other Assets (Details) Details 44 false false R45.htm 995797 - Disclosure - Prepaids and Other Assets - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePrepaidsAndOtherAssetsAdditionalInformationDetails Prepaids and Other Assets - Additional Information (Details) Details 45 false false R46.htm 995807 - Disclosure - Property and Equipment, net - Schedule of Property and equipment, Net (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails Property and Equipment, net - Schedule of Property and equipment, Net (Details) Details 46 false false R47.htm 995817 - Disclosure - Property and Equipment, net - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosurePropertyAndEquipmentNetAdditionalInformationDetails Property and Equipment, net - Additional Information (Details) Details 47 false false R48.htm 995827 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureAccruedExpensesScheduleOfAccruedExpensesDetails Accrued Expenses - Schedule of Accrued Expenses (Details) Details 48 false false R49.htm 995837 - Disclosure - Other Significant Agreements - Paragon Agreement (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureOtherSignificantAgreementsParagonAgreementDetails Other Significant Agreements - Paragon Agreement (Details) Details 49 false false R50.htm 995847 - Disclosure - Other Significant Agreements - WuXi Biologics (Hong Kong) limited agreements (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureOtherSignificantAgreementsWuxiBiologicsHongKongLimitedAgreementsDetails Other Significant Agreements - WuXi Biologics (Hong Kong) limited agreements (Details) Details 50 false false R51.htm 995867 - Disclosure - Common Stock - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureCommonStockAdditionalInformationDetails Common Stock - Additional Information (Details) Details 51 false false R52.htm 995887 - Disclosure - Equity-Based Compensation - Summary of Company's Unvested Restricted Common Stock Award Activity (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationSummaryOfCompanySUnvestedRestrictedCommonStockAwardActivityDetails Equity-Based Compensation - Summary of Company's Unvested Restricted Common Stock Award Activity (Details) Details 52 false false R53.htm 995897 - Disclosure - Equity-Based Compensation - Determining fair value of stock options (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationDeterminingFairValueOfStockOptionsDetails Equity-Based Compensation - Determining fair value of stock options (Details) Details 53 false false R54.htm 995907 - Disclosure - Equity-Based Compensation - Summary of stock option activity (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationSummaryOfStockOptionActivityDetails Equity-Based Compensation - Summary of stock option activity (Details) Details 54 false false R55.htm 995917 - Disclosure - Equity-Based Compensation - Summary of restricted stock unit activity (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationSummaryOfRestrictedStockUnitActivityDetails Equity-Based Compensation - Summary of restricted stock unit activity (Details) Details 55 false false R56.htm 995927 - Disclosure - Equity-Based Compensation - Summary of classification of equity-based compensation expense related to incentive units (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationSummaryOfClassificationOfEquityBasedCompensationExpenseRelatedToIncentiveUnitsDetails Equity-Based Compensation - Summary of classification of equity-based compensation expense related to incentive units (Details) Details 56 false false R57.htm 995937 - Disclosure - Equity-Based Compensation - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureEquityBasedCompensationAdditionalInformationDetails Equity-Based Compensation - Additional Information (Details) Details 57 false false R58.htm 995947 - Disclosure - Related Parties - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetails Related Parties - Additional Information (Details) Details 58 false false R59.htm 995957 - Disclosure - Net Loss Per Share - Basic and diluted net loss per unit attributable to common unitholders (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNetLossPerShareBasicAndDilutedNetLossPerUnitAttributableToCommonUnitholdersDetails Net Loss Per Share - Basic and diluted net loss per unit attributable to common unitholders (Details) Details 59 false false R60.htm 995967 - Disclosure - Net Loss Per Share - Potential common units excluded from calculation of diluted net loss per unit attributable to common unitholders (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureNetLossPerSharePotentialCommonUnitsExcludedFromCalculationOfDilutedNetLossPerUnitAttributableToCommonUnitholdersDetails Net Loss Per Share - Potential common units excluded from calculation of diluted net loss per unit attributable to common unitholders (Details) Details 60 false false R61.htm 995977 - Disclosure - Operating Leases - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureOperatingLeasesAdditionalInformationDetails Operating Leases - Additional Information (Details) Details 61 false false R62.htm 995987 - Disclosure - Segment Information - Additional Information (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformationAdditionalInformationDetails Segment Information - Additional Information (Details) Details 62 false false R63.htm 995997 - Disclosure - Segment Information - Schedule of Operating Segments (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformationScheduleOfOperatingSegmentsDetails Segment Information - Schedule of Operating Segments (Details) Details 63 false false R64.htm 996007 - Disclosure - Segment Information - Schedule of Operating Segments (Parenthetical) (Details) Sheet http://apogeetherapeutics.com/20250331/taxonomy/role/DisclosureSegmentInformationScheduleOfOperatingSegmentsParentheticalDetails Segment Information - Schedule of Operating Segments (Parenthetical) (Details) Details 64 false false All Reports Book All Reports apge-20250331.htm apge-20250331.xsd http://fasb.org/us-gaap/2024 http://xbrl.sec.gov/dei/2024 http://xbrl.sec.gov/ecd/2024 false false